BEPOTASTINE BESILATE

BEPOTASTINE BESILATE was reported 644 times

BEPOTASTINE BESILATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTRAMAMMARY LYMPHADENOPATHY 1 0.2500
1 OESOPHAGEAL SQUAMOUS CELL CARCINOMA STAGE I 1 0.2000
2 INSTILLATION SITE HYPOAESTHESIA 1 0.1429
3 PTERYGIUM OPERATION 1 0.0714
4 OPTIC DISC VASCULAR DISORDER 1 0.0526
5 MUCOSAL PROLAPSE SYNDROME 1 0.0370
6 ALLERGIC PHARYNGITIS 1 0.0294
7 NASAL TURBINATE ABNORMALITY 3 0.0286
8 FUNGAL ABSCESS CENTRAL NERVOUS SYSTEM 2 0.0263
9 INSTILLATION SITE PARAESTHESIA 1 0.0238
10 SCHIZOAFFECTIVE DISORDER DEPRESSIVE TYPE 1 0.0238
11 ROTAVIRUS TEST POSITIVE 1 0.0222
12 AUTOIMMUNE BLISTERING DISEASE 1 0.0217
13 MYRINGOTOMY 1 0.0185
14 TUMOUR FISTULISATION 1 0.0167
15 BURSA INJURY 1 0.0154
16 PUNCTAL PLUG INSERTION 1 0.0143
17 SUBMAXILLARY GLAND ENLARGEMENT 1 0.0139
18 REFEEDING SYNDROME 2 0.0132
19 METASTASES TO SMALL INTESTINE 1 0.0127
20 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
21 PLASTIC SURGERY TO THE FACE 1 0.0120
22 SMALL INTESTINE ADENOCARCINOMA 2 0.0112
23 LARGE INTESTINE CARCINOMA 2 0.0108
24 STITCH ABSCESS 1 0.0105
25 HEPATIC ARTERY ANEURYSM 1 0.0104
26 BILIARY DRAINAGE 1 0.0096
27 ALLERGY TO ARTHROPOD BITE 3 0.0094
28 PERINEAL DISORDER 1 0.0083
29 PORTAL TRACT INFLAMMATION 1 0.0079
30 MYCOPLASMA TEST POSITIVE 1 0.0066
31 VISUAL ACUITY REDUCED TRANSIENTLY 2 0.0065
32 MONONEURITIS 1 0.0064
33 STATUS MIGRAINOSUS 1 0.0062
34 OESOPHAGOGASTRIC FUNDOPLASTY 1 0.0059
35 ANAEMIA FOLATE DEFICIENCY 1 0.0052
36 LIPOEDEMA 2 0.0051
37 POSTOPERATIVE DELIRIUM 1 0.0051
38 INFLUENZA VIRUS TEST POSITIVE 1 0.0047
39 EXPOSURE TO FUNGUS 1 0.0047
40 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 1 0.0045
41 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
42 STATUS ASTHMATICUS 2 0.0042
43 TRI-IODOTHYRONINE FREE DECREASED 1 0.0039
44 CONJUNCTIVITIS VIRAL 1 0.0038
45 HORMONE RECEPTOR POSITIVE BREAST CANCER 1 0.0037
46 ATRIAL ENLARGEMENT 1 0.0037
47 VACCINATION SITE PAIN 2 0.0035
48 CREUTZFELDT-JAKOB DISEASE 1 0.0035
49 COAGULATION TIME ABNORMAL 1 0.0033
50 BLADDER TAMPONADE 1 0.0033
51 CORNEAL INFILTRATES 1 0.0032
52 INCREASED VISCOSITY OF BRONCHIAL SECRETION 2 0.0031
53 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
54 METASTATIC GASTRIC CANCER 1 0.0029
55 METASTATIC CARCINOMA OF THE BLADDER 1 0.0028
56 BRONCHIAL WALL THICKENING 2 0.0028
57 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0027
58 INSTILLATION SITE PRURITUS 1 0.0027
59 LUNG ADENOCARCINOMA STAGE IV 1 0.0026
60 PRODUCT DROPPER ISSUE 2 0.0025
61 INSTILLATION SITE IRRITATION 3 0.0025
62 PARVOVIRUS INFECTION 1 0.0025
63 ENTEROCOCCAL SEPSIS 2 0.0025
64 PROCEDURAL HEADACHE 1 0.0024
65 LICHENIFICATION 1 0.0024
66 CARDIAC STRESS TEST ABNORMAL 2 0.0024
67 GASTRODUODENAL ULCER 1 0.0024
68 LUNG HYPERINFLATION 2 0.0023
69 ARTERIOVENOUS MALFORMATION 2 0.0022
70 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
71 HERNIA PAIN 1 0.0022
72 LIPOATROPHY 2 0.0021
73 INFUSION SITE HAEMATOMA 1 0.0021
74 DUODENAL STENOSIS 1 0.0021
75 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
76 APPLICATION SITE ACNE 1 0.0020
77 ROOT CANAL INFECTION 1 0.0020
78 ORBITAL OEDEMA 1 0.0020
79 EYE ALLERGY 3 0.0019
80 INJURY CORNEAL 1 0.0019
81 TRI-IODOTHYRONINE DECREASED 1 0.0019
82 NASAL INFLAMMATION 2 0.0019
83 BONE CANCER METASTATIC 1 0.0019
84 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
85 ANAL STENOSIS 1 0.0019
86 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
87 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
88 PRODUCT CLOSURE ISSUE 1 0.0018
89 HELICOBACTER TEST POSITIVE 1 0.0018
90 THYROXINE FREE DECREASED 1 0.0018
91 MECHANICAL ILEUS 1 0.0018
92 RADIATION SKIN INJURY 2 0.0017
93 DYSPNOEA AT REST 5 0.0017
94 MEDIASTINITIS 1 0.0017
95 HYPOPITUITARISM 3 0.0017
96 HEPATORENAL FAILURE 1 0.0017
97 MEAN PLATELET VOLUME INCREASED 1 0.0017
98 BLOOD IMMUNOGLOBULIN E INCREASED 4 0.0017
99 PROSTATE CANCER RECURRENT 1 0.0016
100 PLEURAL DISORDER 1 0.0016
101 RECTAL FISSURE 1 0.0016
102 SMALL INTESTINE ULCER 1 0.0015
103 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
104 CATARACT NUCLEAR 1 0.0015
105 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
106 HEAT ILLNESS 1 0.0015
107 CUTANEOUS SYMPTOM 1 0.0015
108 CORNEAL ABRASION 2 0.0015
109 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
110 H1N1 INFLUENZA 2 0.0014
111 GRANULOMATOUS LIVER DISEASE 1 0.0014
112 MONOCYTE PERCENTAGE INCREASED 1 0.0014
113 AUDITORY DISORDER 2 0.0014
114 CERVICAL RADICULOPATHY 1 0.0014
115 MENINGITIS BACTERIAL 2 0.0014
116 BITE 1 0.0014
117 ATROPHIC VULVOVAGINITIS 1 0.0014
118 DIFFERENTIATION SYNDROME 1 0.0014
119 BILIARY DILATATION 2 0.0014
120 CONJUNCTIVITIS ALLERGIC 2 0.0013
121 RHINITIS ALLERGIC 6 0.0013
122 CHRONIC SINUSITIS 5 0.0013
123 BASOPHIL COUNT INCREASED 1 0.0013
124 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
125 CORNEAL TRANSPLANT 1 0.0013
126 METAPNEUMOVIRUS INFECTION 1 0.0013
127 TOE OPERATION 1 0.0013
128 EYELID EXFOLIATION 1 0.0013
129 DEVICE DAMAGE 1 0.0013
130 HEMIANAESTHESIA 1 0.0013
131 BREAST CALCIFICATIONS 1 0.0013
132 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
133 SINUSITIS FUNGAL 1 0.0012
134 REACTION TO PRESERVATIVES 1 0.0012
135 ERYTHRODERMIC PSORIASIS 1 0.0012
136 INSTILLATION SITE PAIN 3 0.0012
137 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
138 GIANT CELL ARTERITIS 1 0.0012
139 OESOPHAGEAL PERFORATION 1 0.0012
140 MEAN PLATELET VOLUME DECREASED 1 0.0012
141 CANCER PAIN 3 0.0012
142 MEDICATION OVERUSE HEADACHE 1 0.0012
143 RELAPSING-REMITTING MULTIPLE SCLEROSIS 1 0.0012
144 INFUSION SITE DISCOLOURATION 1 0.0011
145 ANEURYSM RUPTURED 1 0.0011
146 ENTEROCOLITIS INFECTIOUS 1 0.0011
147 TEMPORAL ARTERITIS 1 0.0011
148 PRODUCT AFTER TASTE 1 0.0010
149 PANCREATIC CYST 2 0.0010
150 FOREIGN BODY IN EYE 1 0.0010
151 EYELID MARGIN CRUSTING 3 0.0010
152 RED BLOOD CELLS URINE POSITIVE 1 0.0010
153 IMMUNE-MEDIATED HEPATIC DISORDER 2 0.0010
154 ANTIBIOTIC THERAPY 1 0.0010
155 JOINT NOISE 2 0.0010
156 OCCULT BLOOD POSITIVE 2 0.0010
157 PRINZMETAL ANGINA 1 0.0010
158 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
159 KERATITIS 3 0.0010
160 BLADDER DYSFUNCTION 1 0.0010
161 ABSCESS JAW 1 0.0010
162 TONSILLITIS 5 0.0010
163 URINARY BLADDER HAEMORRHAGE 2 0.0009
164 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
165 ANAEMIA MACROCYTIC 2 0.0009
166 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
167 TRAUMATIC HAEMATOMA 1 0.0009
168 AMAUROSIS FUGAX 1 0.0009
169 GALLBLADDER ENLARGEMENT 1 0.0009
170 VULVOVAGINAL DRYNESS 3 0.0009
171 INSTILLATION SITE REACTION 1 0.0009
172 CORNEAL DISORDER 2 0.0009
173 BACTERIAL TEST POSITIVE 2 0.0009
174 PUPILS UNEQUAL 1 0.0009
175 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
176 MENOPAUSAL SYMPTOMS 2 0.0009
177 ERYTHEMA MULTIFORME 8 0.0009
178 FULL BLOOD COUNT INCREASED 1 0.0008
179 RENAL TUBULAR INJURY 1 0.0008
180 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
181 TOOTH EROSION 1 0.0008
182 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
183 EYELID IRRITATION 2 0.0008
184 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
185 OBSTRUCTION GASTRIC 1 0.0008
186 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
187 ADJUSTMENT DISORDER 1 0.0008
188 URINE OUTPUT INCREASED 2 0.0008
189 ABDOMINAL MASS 2 0.0007
190 BREAST MASS 5 0.0007
191 SKIN WRINKLING 2 0.0007
192 CARBON DIOXIDE INCREASED 1 0.0007
193 CALCULUS BLADDER 1 0.0007
194 NASAL DISCHARGE DISCOLOURATION 1 0.0007
195 PRERENAL FAILURE 1 0.0007
196 PERIORBITAL SWELLING 4 0.0007
197 GENITAL RASH 1 0.0007
198 NAIL INFECTION 1 0.0007
199 FAT TISSUE INCREASED 1 0.0007
200 PULMONARY PAIN 2 0.0007
201 PANCREATIC ENZYMES INCREASED 1 0.0007
202 RED BLOOD CELL COUNT ABNORMAL 1 0.0007
203 AXILLARY PAIN 1 0.0007
204 IMPETIGO 1 0.0007
205 GASTROINTESTINAL WALL THICKENING 1 0.0007
206 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
207 GENITAL HERPES 1 0.0007
208 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
209 MEAN CELL VOLUME DECREASED 1 0.0006
210 NEPHROGENIC ANAEMIA 3 0.0006
211 GASTROSTOMY 1 0.0006
212 EYELIDS PRURITUS 2 0.0006
213 EOSINOPHILIC PNEUMONIA 2 0.0006
214 KERATOPATHY 1 0.0006
215 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
216 SUBCUTANEOUS ABSCESS 3 0.0006
217 CUSHINGOID 2 0.0006
218 DEAFNESS NEUROSENSORY 2 0.0006
219 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
220 CONJUNCTIVITIS 11 0.0006
221 FEMALE GENITAL TRACT FISTULA 1 0.0006
222 INTERNATIONAL NORMALISED RATIO ABNORMAL 2 0.0006
223 APLASIA PURE RED CELL 2 0.0006
224 ONYCHOCLASIS 4 0.0006
225 BLOOD CHLORIDE INCREASED 1 0.0006
226 PAPILLARY THYROID CANCER 1 0.0006
227 SPINAL CORD INJURY 1 0.0006
228 ROTATOR CUFF REPAIR 1 0.0006
229 KYPHOSIS 1 0.0006
230 EYE PRURITUS 19 0.0006
231 TERMINAL INSOMNIA 1 0.0006
232 BREAST CYST 1 0.0006
233 INDURATION 1 0.0006
234 COMPRESSION FRACTURE 3 0.0006
235 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
236 EYE IRRITATION 32 0.0006
237 ERYTHEMA OF EYELID 3 0.0006
238 PNEUMOMEDIASTINUM 1 0.0006
239 MONOCYTE COUNT INCREASED 2 0.0006
240 ESSENTIAL HYPERTENSION 1 0.0005
241 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
242 DENTAL CARE 1 0.0005
243 PLASMACYTOMA 1 0.0005
244 AURA 1 0.0005
245 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
246 PROTEIN TOTAL DECREASED 2 0.0005
247 BILE DUCT OBSTRUCTION 1 0.0005
248 HYPERCOAGULATION 1 0.0005
249 GASTRIC INFECTION 2 0.0005
250 NASAL SEPTUM DEVIATION 1 0.0005
251 ANORECTAL DISORDER 1 0.0005
252 HYPOPHYSITIS 1 0.0005
253 HYPERPARATHYROIDISM 1 0.0005
254 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
255 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
256 EOSINOPHIL COUNT INCREASED 4 0.0005
257 EXOPHTHALMOS 1 0.0005
258 INFUSION SITE BRUISING 1 0.0005
259 VULVOVAGINAL DISCOMFORT 2 0.0005
260 PHYSICAL DISABILITY 2 0.0005
261 GASTROINTESTINAL ULCER 1 0.0005
262 TONGUE BLISTERING 1 0.0004
263 FEAR OF DEATH 1 0.0004
264 PRODUCT TASTE ABNORMAL 6 0.0004
265 LARGE INTESTINE POLYP 3 0.0004
266 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
267 SKIN ABRASION 2 0.0004
268 TUMOUR MARKER INCREASED 2 0.0004
269 RADIUS FRACTURE 1 0.0004
270 ADRENAL INSUFFICIENCY 5 0.0004
271 SKIN FRAGILITY 1 0.0004
272 DERMAL CYST 1 0.0004
273 STAPHYLOCOCCAL SEPSIS 2 0.0004
274 PHARYNGITIS 5 0.0004
275 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
276 HYPERPARATHYROIDISM SECONDARY 1 0.0004
277 PEMPHIGOID 3 0.0004
278 TOXIC SKIN ERUPTION 4 0.0004
279 METASTASES TO PERITONEUM 1 0.0004
280 TUBERCULIN TEST POSITIVE 1 0.0004
281 TOXIC ENCEPHALOPATHY 2 0.0004
282 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
283 MEAN CELL VOLUME INCREASED 1 0.0004
284 ROTATOR CUFF SYNDROME 5 0.0004
285 BLOOD CHLORIDE DECREASED 1 0.0004
286 CATHETER SITE PAIN 1 0.0004
287 GASTROINTESTINAL INFLAMMATION 3 0.0004
288 OCULAR HYPERAEMIA 18 0.0004
289 BLOOD ALBUMIN DECREASED 3 0.0004
290 ANIMAL BITE 1 0.0004
291 ABDOMINAL RIGIDITY 1 0.0004
292 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
293 SKIN LACERATION 4 0.0004
294 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
295 SERUM SICKNESS 1 0.0004
296 MACULAR OEDEMA 2 0.0004
297 OCULAR DISCOMFORT 4 0.0004
298 VITAMIN D DECREASED 3 0.0004
299 DUODENAL ULCER HAEMORRHAGE 1 0.0003
300 HEART VALVE INCOMPETENCE 1 0.0003
301 HEPATIC FUNCTION ABNORMAL 13 0.0003
302 STRABISMUS 1 0.0003
303 DRUG ERUPTION 6 0.0003
304 PLEURISY 2 0.0003
305 GALLBLADDER DISORDER 6 0.0003
306 REBOUND ACID HYPERSECRETION 1 0.0003
307 BLOOD COUNT ABNORMAL 5 0.0003
308 VULVOVAGINAL BURNING SENSATION 2 0.0003
309 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
310 HEPATIC STEATOSIS 6 0.0003
311 DRY EYE 16 0.0003
312 PRE-EXISTING CONDITION IMPROVED 2 0.0003
313 BLOOD CREATININE DECREASED 1 0.0003
314 EYE PAIN 18 0.0003
315 BREAST CANCER RECURRENT 1 0.0003
316 EYE INFLAMMATION 3 0.0003
317 BILE DUCT STONE 1 0.0003
318 OBESITY 5 0.0003
319 TREATMENT FAILURE 26 0.0003
320 FOREIGN BODY SENSATION IN EYES 2 0.0003
321 SNEEZING 7 0.0003
322 LIVER ABSCESS 1 0.0003
323 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
324 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
325 LYMPHOCYTE COUNT INCREASED 1 0.0003
326 OTITIS MEDIA 1 0.0003
327 LACRIMATION INCREASED 9 0.0003
328 DYSGEUSIA 22 0.0003
329 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
330 LYMPHOEDEMA 2 0.0003
331 EYE DISCHARGE 3 0.0003
332 DRUG-INDUCED LIVER INJURY 9 0.0003
333 EXTRASYSTOLES 2 0.0003
334 BRONCHIOLITIS 1 0.0003
335 SEASONAL ALLERGY 4 0.0003
336 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
337 BREAST CANCER METASTATIC 3 0.0003
338 FACIAL BONES FRACTURE 1 0.0003
339 APPARENT DEATH 1 0.0003
340 BONE LESION 1 0.0003
341 AUTOIMMUNE THYROIDITIS 1 0.0003
342 MYOCARDIAL ISCHAEMIA 3 0.0003
343 COMMUNICATION DISORDER 1 0.0003
344 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
345 OESOPHAGEAL PAIN 1 0.0003
346 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
347 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
348 NASAL DISCOMFORT 2 0.0003
349 HYPOTHYROIDISM 8 0.0003
350 BLOOD PRESSURE FLUCTUATION 6 0.0002
351 TRIGEMINAL NEURALGIA 1 0.0002
352 ENURESIS 1 0.0002
353 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
354 AORTIC DISSECTION 1 0.0002
355 SOCIAL PROBLEM 1 0.0002
356 LUNG NEOPLASM 1 0.0002
357 PULMONARY TUBERCULOSIS 1 0.0002
358 JOINT INJURY 5 0.0002
359 MYDRIASIS 3 0.0002
360 PRODUCT CONTAINER ISSUE 2 0.0002
361 ABNORMAL SENSATION IN EYE 1 0.0002
362 HORDEOLUM 1 0.0002
363 OCULAR ICTERUS 1 0.0002
364 DIVERTICULUM INTESTINAL 1 0.0002
365 SPINAL OSTEOARTHRITIS 2 0.0002
366 TUMOUR LYSIS SYNDROME 2 0.0002
367 LIGAMENT RUPTURE 1 0.0002
368 ILEUS PARALYTIC 1 0.0002
369 FACIAL PAIN 2 0.0002
370 GASTROOESOPHAGEAL REFLUX DISEASE 18 0.0002
371 ANAL INCONTINENCE 2 0.0002
372 TOOTHACHE 4 0.0002
373 LIMB INJURY 6 0.0002
374 NEUTROPHIL COUNT DECREASED 9 0.0002
375 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
376 END STAGE RENAL DISEASE 4 0.0002
377 EXOSTOSIS 2 0.0002
378 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
379 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
380 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
381 EYE OPERATION 1 0.0002
382 COORDINATION ABNORMAL 3 0.0002
383 EYE SWELLING 8 0.0002
384 MULTIPLE MYELOMA 1 0.0002
385 FLANK PAIN 2 0.0002
386 TIBIA FRACTURE 1 0.0002
387 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
388 PHOTOPHOBIA 4 0.0002
389 ASTHMA 24 0.0002
390 FOOT FRACTURE 4 0.0002
391 SPUTUM DISCOLOURED 2 0.0002
392 SARCOIDOSIS 1 0.0002
393 CARDIAC TAMPONADE 1 0.0002
394 SLEEP APNOEA SYNDROME 4 0.0002
395 HUMERUS FRACTURE 1 0.0002
396 FINGER DEFORMITY 1 0.0002
397 HORMONE LEVEL ABNORMAL 1 0.0002
398 PHARYNGEAL SWELLING 2 0.0002
399 NASAL CONGESTION 12 0.0002
400 VITREOUS FLOATERS 2 0.0002
401 WHEEZING 12 0.0002
402 EXPIRED DRUG ADMINISTERED 1 0.0002
403 FOOT OPERATION 1 0.0002
404 SINUS DISORDER 4 0.0002
405 INABILITY TO AFFORD MEDICATION 2 0.0002
406 ANEURYSM 1 0.0002
407 INJECTION SITE INFLAMMATION 1 0.0002
408 PROTEIN URINE PRESENT 1 0.0002
409 DERMATITIS EXFOLIATIVE 1 0.0002
410 CORONARY ARTERY STENOSIS 1 0.0002
411 OSTEOPENIA 3 0.0002
412 DRUG TOLERANCE 1 0.0002
413 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
414 TASTE DISORDER 4 0.0002
415 ENDOCARDITIS 1 0.0002
416 PRODUCT COLOUR ISSUE 1 0.0002
417 CACHEXIA 1 0.0002
418 MUSCULOSKELETAL CHEST PAIN 3 0.0002
419 TEMPERATURE INTOLERANCE 2 0.0002
420 TRISMUS 1 0.0002
421 POOR VENOUS ACCESS 2 0.0002
422 SWOLLEN TONGUE 6 0.0002
423 SENSITIVITY TO WEATHER CHANGE 1 0.0002
424 PNEUMOTHORAX 3 0.0002
425 FOOD POISONING 1 0.0002
426 IRRITABLE BOWEL SYNDROME 4 0.0002
427 BRUXISM 1 0.0002
428 THROAT TIGHTNESS 5 0.0002
429 BACK INJURY 2 0.0002
430 BLOOD GLUCOSE FLUCTUATION 2 0.0002
431 ASTHENOPIA 1 0.0002
432 HYPERKERATOSIS 1 0.0002
433 VENTRICULAR FIBRILLATION 2 0.0002
434 MALNUTRITION 2 0.0002
435 BLOOD CALCIUM DECREASED 2 0.0002
436 EYE INFECTION 2 0.0002
437 CHOLECYSTITIS ACUTE 1 0.0002
438 SINUSITIS 18 0.0002
439 MUSCULOSKELETAL DISCOMFORT 3 0.0002
440 HERPES VIRUS INFECTION 1 0.0002
441 ENTEROCOLITIS 1 0.0002
442 RALES 1 0.0002
443 EYELID OEDEMA 2 0.0002
444 STRESS CARDIOMYOPATHY 1 0.0002
445 VASCULITIS 2 0.0002
446 CHRONIC KIDNEY DISEASE 13 0.0002
447 HEART RATE DECREASED 6 0.0002
448 DECREASED INTEREST 1 0.0002
449 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
450 PROTHROMBIN TIME PROLONGED 1 0.0002
451 RESPIRATORY DISORDER 5 0.0002
452 TYPE 1 DIABETES MELLITUS 1 0.0002
453 STOMATITIS 10 0.0002
454 INGUINAL HERNIA 1 0.0002
455 DERMATITIS ACNEIFORM 1 0.0002
456 TENDON RUPTURE 2 0.0002
457 DRUG DIVERSION 1 0.0002
458 INFUSION SITE SWELLING 1 0.0002
459 BLEPHAROSPASM 1 0.0002
460 PHOTOPSIA 1 0.0002
461 THERAPY CESSATION 8 0.0002
462 GLAUCOMA 3 0.0002
463 NIGHT SWEATS 5 0.0002
464 HIATUS HERNIA 2 0.0002
465 EAR PAIN 3 0.0002
466 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
467 BEDRIDDEN 2 0.0002
468 EYE DISORDER 5 0.0002
469 DYSGRAPHIA 1 0.0002
470 DISABILITY 3 0.0002
471 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
472 HAEMATOCRIT DECREASED 3 0.0002
473 UPPER LIMB FRACTURE 3 0.0002
474 BLOOD CHOLESTEROL INCREASED 7 0.0002
475 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
476 BRONCHIECTASIS 1 0.0001
477 POSTOPERATIVE WOUND INFECTION 1 0.0001
478 IMPAIRED GASTRIC EMPTYING 2 0.0001
479 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
480 EYE MOVEMENT DISORDER 1 0.0001
481 RESPIRATION ABNORMAL 1 0.0001
482 HAIR GROWTH ABNORMAL 1 0.0001
483 LARGE INTESTINE PERFORATION 1 0.0001
484 MASS 2 0.0001
485 CARPAL TUNNEL SYNDROME 2 0.0001
486 OXYGEN SATURATION DECREASED 8 0.0001
487 PAPULE 1 0.0001
488 DUODENAL ULCER 1 0.0001
489 SLEEP DISORDER 10 0.0001
490 METASTASIS 1 0.0001
491 RED BLOOD CELL COUNT DECREASED 4 0.0001
492 SUBDURAL HAEMATOMA 2 0.0001
493 VISION BLURRED 19 0.0001
494 TONGUE DISORDER 1 0.0001
495 FAECES SOFT 1 0.0001
496 ORAL DISORDER 1 0.0001
497 PULMONARY MASS 2 0.0001
498 DYSPNOEA EXERTIONAL 5 0.0001
499 HYPOAESTHESIA ORAL 2 0.0001
500 ECONOMIC PROBLEM 2 0.0001
501 PRODUCT AVAILABILITY ISSUE 3 0.0001
502 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
503 HEPATOCELLULAR CARCINOMA 1 0.0001
504 AORTIC ANEURYSM 1 0.0001
505 HEART RATE INCREASED 13 0.0001
506 HYPERTHERMIA 1 0.0001
507 HIP ARTHROPLASTY 2 0.0001
508 MUSCLE TWITCHING 3 0.0001
509 CONCUSSION 1 0.0001
510 APHTHOUS ULCER 1 0.0001
511 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
512 EJECTION FRACTION DECREASED 2 0.0001
513 HYPOALBUMINAEMIA 1 0.0001
514 PELVIC FRACTURE 1 0.0001
515 MULTIPLE ALLERGIES 1 0.0001
516 CYSTITIS 4 0.0001
517 NECK PAIN 7 0.0001
518 STENT PLACEMENT 1 0.0001
519 MYASTHENIA GRAVIS 1 0.0001
520 PRESYNCOPE 3 0.0001
521 BLOOD POTASSIUM INCREASED 2 0.0001
522 METASTASES TO BONE 2 0.0001
523 BRONCHITIS 9 0.0001
524 SPINAL COMPRESSION FRACTURE 1 0.0001
525 EXPIRED PRODUCT ADMINISTERED 4 0.0001
526 OROPHARYNGEAL PAIN 11 0.0001
527 SENSATION OF FOREIGN BODY 1 0.0001
528 ABDOMINAL PAIN LOWER 3 0.0001
529 INFUSION SITE ERYTHEMA 1 0.0001
530 GASTRIC CANCER 3 0.0001
531 OSTEOARTHRITIS 5 0.0001
532 PSEUDOMONAS INFECTION 1 0.0001
533 MUSCLE STRAIN 1 0.0001
534 PYELONEPHRITIS 1 0.0001
535 SKIN SWELLING 1 0.0001
536 ANHEDONIA 3 0.0001
537 BLOOD CALCIUM INCREASED 1 0.0001
538 GROIN PAIN 1 0.0001
539 METASTASES TO LIVER 2 0.0001
540 GRIP STRENGTH DECREASED 1 0.0001
541 RESPIRATORY RATE INCREASED 1 0.0001
542 JAUNDICE 3 0.0001
543 THROAT IRRITATION 5 0.0001
544 BLOOD BILIRUBIN INCREASED 3 0.0001
545 LUPUS-LIKE SYNDROME 1 0.0001
546 GASTROINTESTINAL CARCINOMA 1 0.0001
547 OPTIC NEURITIS 1 0.0001
548 NEPHROLITHIASIS 5 0.0001
549 PNEUMONIA BACTERIAL 1 0.0001
550 INCREASED TENDENCY TO BRUISE 1 0.0001
551 DYSURIA 4 0.0001
552 IRON DEFICIENCY ANAEMIA 1 0.0001
553 RHINORRHOEA 7 0.0001
554 BREAST CANCER STAGE I 1 0.0001
555 PRODUCT DISTRIBUTION ISSUE 1 0.0001
556 AGRANULOCYTOSIS 2 0.0001
557 HAEMOPTYSIS 3 0.0001
558 THINKING ABNORMAL 2 0.0001
559 HEPATIC ENCEPHALOPATHY 1 0.0001
560 NEPHROPATHY 1 0.0001
561 BLOOD URINE PRESENT 2 0.0001
562 PRODUCT PACKAGING ISSUE 1 0.0001
563 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
564 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
565 HYPERCHOLESTEROLAEMIA 1 0.0001
566 HERNIA 2 0.0001
567 ERUCTATION 2 0.0001
568 HEPATOMEGALY 1 0.0001
569 KNEE OPERATION 1 0.0001
570 LIGAMENT SPRAIN 1 0.0001
571 PRESCRIBED UNDERDOSE 2 0.0001
572 BLOOD POTASSIUM DECREASED 3 0.0001
573 EMPHYSEMA 1 0.0001
574 PLEURAL EFFUSION 6 0.0001
575 EYELID PTOSIS 1 0.0001
576 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
577 DRUG LEVEL DECREASED 1 0.0001
578 TOOTH ABSCESS 1 0.0001
579 NEUTROPHIL COUNT INCREASED 1 0.0001
580 EAR DISCOMFORT 1 0.0001
581 HELICOBACTER INFECTION 1 0.0001
582 OSTEOPOROSIS 4 0.0001
583 RIB FRACTURE 2 0.0001
584 POLLAKIURIA 4 0.0001
585 RETCHING 2 0.0001
586 BREAST PAIN 1 0.0001
587 DECREASED ACTIVITY 1 0.0001
588 PHARYNGITIS STREPTOCOCCAL 1 0.0001
589 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
590 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
591 CHOLELITHIASIS 3 0.0001
592 INJECTION SITE NODULE 1 0.0001
593 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
594 VIRAL INFECTION 3 0.0001
595 URINARY RETENTION 3 0.0001
596 INTESTINAL PERFORATION 1 0.0001
597 STATUS EPILEPTICUS 1 0.0001
598 REBOUND EFFECT 1 0.0001
599 MICTURITION URGENCY 1 0.0001
600 HERPES ZOSTER 5 0.0001
601 NEOPLASM 1 0.0001
602 NIGHTMARE 3 0.0001
603 PERICARDIAL EFFUSION 2 0.0001
604 MADAROSIS 1 0.0001
605 ELECTROLYTE IMBALANCE 1 0.0001
606 SEXUAL DYSFUNCTION 1 0.0001
607 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
608 CATARACT 5 0.0001
609 CHOLECYSTITIS 1 0.0001
610 MIGRAINE 8 0.0001
611 ACCIDENT 1 0.0001
612 HYPERLIPIDAEMIA 1 0.0001
613 POLYNEUROPATHY 1 0.0001
614 THYROID CANCER 1 0.0001
615 INTERSTITIAL LUNG DISEASE 4 0.0001
616 HYPOGLYCAEMIA 4 0.0001
617 THERAPEUTIC RESPONSE DECREASED 5 0.0001
618 C-REACTIVE PROTEIN INCREASED 3 0.0001
619 BURSITIS 1 0.0001
620 HYPERGLYCAEMIA 3 0.0001
621 SCHIZOPHRENIA 1 0.0001
622 CEREBRAL INFARCTION 2 0.0001
623 LUNG DISORDER 4 0.0001
624 MUSCLE SPASTICITY 1 0.0001
625 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
626 SPINAL OPERATION 1 0.0001
627 HYPERCALCAEMIA 1 0.0001
628 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
629 INJECTION SITE DISCOLOURATION 1 0.0001
630 SECRETION DISCHARGE 1 0.0001
631 HOT FLUSH 6 0.0001
632 DERMATITIS ALLERGIC 1 0.0001
633 INTRAOCULAR PRESSURE INCREASED 1 0.0001
634 HEPATITIS 2 0.0001
635 CHEST DISCOMFORT 8 0.0001
636 DRUG RESISTANCE 2 0.0001
637 URTICARIA 13 0.0001
638 INJECTION SITE INDURATION 1 0.0001
639 SWELLING FACE 5 0.0001
640 NODULE 1 0.0001
641 ANKYLOSING SPONDYLITIS 1 0.0001
642 FEBRILE NEUTROPENIA 5 0.0001
643 PLATELET COUNT DECREASED 8 0.0001
644 EYE HAEMORRHAGE 1 0.0001
645 HAIR TEXTURE ABNORMAL 1 0.0001
646 QUALITY OF LIFE DECREASED 1 0.0001
647 DRUG EFFECT DECREASED 4 0.0001
648 FREQUENT BOWEL MOVEMENTS 2 0.0001
649 OEDEMA 4 0.0001
650 BLINDNESS 3 0.0001
651 GINGIVAL BLEEDING 1 0.0001
652 LUNG NEOPLASM MALIGNANT 3 0.0001
653 SKIN LESION 2 0.0001
654 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
655 PERIPHERAL COLDNESS 1 0.0001
656 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
657 ROAD TRAFFIC ACCIDENT 3 0.0001
658 APHONIA 1 0.0001
659 ABDOMINAL DISCOMFORT 12 0.0001
660 RENAL IMPAIRMENT 6 0.0001
661 INJURY 5 0.0001
662 SKIN REACTION 1 0.0001
663 BLINDNESS UNILATERAL 1 0.0001
664 LYMPHOPENIA 1 0.0001
665 PRURITUS 27 0.0001
666 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
667 MYELODYSPLASTIC SYNDROME 1 0.0001
668 BACK PAIN 16 0.0001
669 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
670 MUSCULOSKELETAL STIFFNESS 6 0.0001
671 DYSPHONIA 4 0.0001
672 HAEMOGLOBIN DECREASED 7 0.0001
673 ANGIOEDEMA 3 0.0001
674 LABORATORY TEST ABNORMAL 2 0.0001
675 COUGH 19 0.0001
676 LIVER DISORDER 3 0.0001
677 INSOMNIA 18 0.0001
678 URINARY INCONTINENCE 2 0.0001
679 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
680 COLON CANCER 1 0.0001
681 IMMUNODEFICIENCY 1 0.0001
682 ABDOMINAL DISTENSION 7 0.0001
683 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
684 EPISTAXIS 5 0.0001
685 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
686 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
687 CONDITION AGGRAVATED 20 0.0001
688 DIABETES MELLITUS 5 0.0001
689 DISCOMFORT 4 0.0001
690 EPILEPSY 2 0.0001
691 TINNITUS 3 0.0001
692 FEELING HOT 4 0.0001
693 PHARYNGEAL OEDEMA 1 0.0001
694 DECREASED APPETITE 15 0.0001
695 FEMUR FRACTURE 2 0.0001
696 THERAPY PARTIAL RESPONDER 1 0.0001
697 ARTHRITIS 5 0.0001
698 PRODUCT USE COMPLAINT 1 0.0001
699 DYSPHAGIA 6 0.0001
700 RESPIRATORY TRACT CONGESTION 1 0.0001
701 RASH ERYTHEMATOUS 3 0.0001
702 SCIATICA 1 0.0001
703 ABSCESS 1 0.0001
704 BLOOD GLUCOSE DECREASED 3 0.0001
705 CONTUSION 6 0.0001
706 SENSORY DISTURBANCE 1 0.0001
707 LACTIC ACIDOSIS 2 0.0001
708 MUSCLE TIGHTNESS 1 0.0001
709 MULTIPLE FRACTURES 1 0.0001
710 RENAL FAILURE 8 0.0001
711 VISUAL ACUITY REDUCED 2 0.0001
712 SKIN DISORDER 2 0.0001
713 BLOOD UREA INCREASED 1 0.0001
714 CELLULITIS 3 0.0001
715 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
716 PRODUCT QUALITY ISSUE 8 0.0001
717 BLOOD PRESSURE INCREASED 9 0.0001
718 CIRCULATORY COLLAPSE 1 0.0001
719 PNEUMONIA 19 0.0001
720 FEELING ABNORMAL 14 0.0001
721 ERYTHEMA 12 0.0001
722 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
723 HEADACHE 36 0.0001
724 LOCAL SWELLING 1 0.0001
725 MUSCULOSKELETAL PAIN 3 0.0001
726 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
727 EOSINOPHILIA 1 0.0001
728 HYPERKALAEMIA 2 0.0001
729 DERMATITIS ATOPIC 3 0.0001
730 COLD SWEAT 1 0.0001
731 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
732 LYMPHOCYTE COUNT DECREASED 1 0.0001
733 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
734 LYMPHADENOPATHY 2 0.0001
735 THIRST 1 0.0001
736 CEREBRAL HAEMORRHAGE 2 0.0001
737 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
738 GASTROENTERITIS VIRAL 1 0.0001
739 ARTHRALGIA 23 0.0001
740 LEUKOCYTOSIS 1 0.0001
741 DRUG EFFECT INCOMPLETE 2 0.0001
742 RESTLESS LEGS SYNDROME 1 0.0001
743 BONE DISORDER 1 0.0001
744 ACCIDENTAL OVERDOSE 2 0.0001
745 ANAPHYLACTIC REACTION 3 0.0001
746 INJECTION SITE MASS 2 0.0001
747 ARTHROPATHY 3 0.0001
748 HYPERSENSITIVITY 10 0.0001
749 BACTERIAL INFECTION 1 0.0001
750 MIDDLE INSOMNIA 1 0.0001
751 HYPONATRAEMIA 3 0.0001
752 HEPATIC CIRRHOSIS 1 0.0001
753 DYSARTHRIA 2 0.0001
754 INTESTINAL OBSTRUCTION 2 0.0001
755 BLOOD SODIUM DECREASED 1 0.0001
756 COLITIS 2 0.0001
757 NEUROPATHY PERIPHERAL 5 0.0001
758 DEHYDRATION 7 0.0001
759 FEELING JITTERY 1 0.0001
760 MALAISE 23 0.0001
761 LETHARGY 3 0.0001
762 PULMONARY FIBROSIS 1 0.0001
763 PRODUCT SUBSTITUTION ISSUE 3 0.0001
764 POST PROCEDURAL COMPLICATION 1 0.0001
765 DRUG PRESCRIBING ERROR 1 0.0001
766 HYPERTENSION 11 0.0001
767 PRESCRIBED OVERDOSE 1 0.0001
768 DYSTONIA 1 0.0001
769 PALPITATIONS 6 0.0001
770 ORAL HERPES 1 0.0001
771 CHILLS 6 0.0001
772 FALL 17 0.0001
773 KIDNEY INFECTION 1 0.0001
774 ALOPECIA 10 0.0001
775 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
776 DISORIENTATION 2 0.0001
777 CONSTIPATION 11 0.0001
778 BLOOD PRESSURE ABNORMAL 1 0.0001
779 CYTOKINE RELEASE SYNDROME 1 0.0000
780 HYPOTENSION 10 0.0000
781 FULL BLOOD COUNT DECREASED 1 0.0000
782 EMOTIONAL DISTRESS 6 0.0000
783 ILL-DEFINED DISORDER 3 0.0000
784 BONE MARROW FAILURE 1 0.0000
785 ANXIETY 14 0.0000
786 PYREXIA 17 0.0000
787 INJECTION SITE WARMTH 1 0.0000
788 PULMONARY HYPERTENSION 1 0.0000
789 DERMATITIS 1 0.0000
790 KNEE ARTHROPLASTY 1 0.0000
791 PAIN 29 0.0000
792 ANAEMIA 9 0.0000
793 EATING DISORDER 1 0.0000
794 IMPAIRED WORK ABILITY 1 0.0000
795 INTENTIONAL OVERDOSE 3 0.0000
796 LIVER FUNCTION TEST INCREASED 1 0.0000
797 HYPERHIDROSIS 6 0.0000
798 WEIGHT DECREASED 13 0.0000
799 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
800 FAECES DISCOLOURED 1 0.0000
801 SEPTIC SHOCK 2 0.0000
802 MENTAL DISORDER 2 0.0000
803 RASH 20 0.0000
804 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
805 MELAENA 1 0.0000
806 INFUSION RELATED REACTION 3 0.0000
807 STEVENS-JOHNSON SYNDROME 1 0.0000
808 RASH MACULO-PAPULAR 1 0.0000
809 INFLUENZA 5 0.0000
810 GLOSSODYNIA 1 0.0000
811 RASH PAPULAR 1 0.0000
812 THERAPY NON-RESPONDER 2 0.0000
813 PANCREATITIS ACUTE 1 0.0000
814 HEART RATE IRREGULAR 1 0.0000
815 DYSPNOEA 25 0.0000
816 HEPATIC ENZYME INCREASED 3 0.0000
817 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
818 DEPRESSION 10 0.0000
819 ABDOMINAL PAIN UPPER 9 0.0000
820 SKIN DISCOLOURATION 2 0.0000
821 NASOPHARYNGITIS 8 0.0000
822 DIARRHOEA 28 0.0000
823 HYPOKALAEMIA 2 0.0000
824 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
825 COGNITIVE DISORDER 2 0.0000
826 BLOOD GLUCOSE INCREASED 8 0.0000
827 PRODUCT PRESCRIBING ERROR 1 0.0000
828 THERAPY INTERRUPTED 3 0.0000
829 NAUSEA 33 0.0000
830 DIABETIC KETOACIDOSIS 1 0.0000
831 HEPATIC CANCER 1 0.0000
832 JOINT SWELLING 5 0.0000
833 LOCALISED INFECTION 1 0.0000
834 FIBROMYALGIA 1 0.0000
835 NEURALGIA 1 0.0000
836 FATIGUE 32 0.0000
837 DYSPEPSIA 4 0.0000
838 VISUAL IMPAIRMENT 5 0.0000
839 WEIGHT INCREASED 9 0.0000
840 MYOCARDIAL INFARCTION 7 0.0000
841 ASTHENIA 15 0.0000
842 UNEVALUABLE EVENT 3 0.0000
843 FLUID RETENTION 2 0.0000
844 ACUTE KIDNEY INJURY 6 0.0000
845 LOSS OF CONSCIOUSNESS 5 0.0000
846 PERIPHERAL SWELLING 6 0.0000
847 ANAPHYLACTIC SHOCK 1 0.0000
848 ABDOMINAL PAIN 9 0.0000
849 RASH GENERALISED 1 0.0000
850 DIPLOPIA 1 0.0000
851 RESPIRATORY TRACT INFECTION 1 0.0000
852 NERVOUSNESS 2 0.0000
853 SEDATION 1 0.0000
854 SPEECH DISORDER 2 0.0000
855 GASTRITIS 1 0.0000
856 EAR INFECTION 1 0.0000
857 CARDIAC FAILURE CONGESTIVE 3 0.0000
858 PALLOR 1 0.0000
859 PNEUMONITIS 1 0.0000
860 CARDIAC ARREST 3 0.0000
861 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
862 RESPIRATORY ARREST 1 0.0000
863 ABNORMAL DREAMS 1 0.0000
864 DIZZINESS 18 0.0000
865 BLISTER 2 0.0000
866 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
867 PAIN IN JAW 1 0.0000
868 MYALGIA 6 0.0000
869 FLATULENCE 2 0.0000
870 RHEUMATOID ARTHRITIS 4 0.0000
871 URINARY TRACT INFECTION 6 0.0000
872 INTENTIONAL DOSE OMISSION 1 0.0000
873 BALANCE DISORDER 3 0.0000
874 LIVER FUNCTION TEST ABNORMAL 1 0.0000
875 DRUG INEFFECTIVE 45 0.0000
876 SURGERY 2 0.0000
877 PAIN IN EXTREMITY 10 0.0000
878 RENAL INJURY 1 0.0000
879 GASTROINTESTINAL DISORDER 3 0.0000
880 OEDEMA PERIPHERAL 4 0.0000
881 VERTIGO 2 0.0000
882 MUSCLE SPASMS 6 0.0000
883 INJECTION SITE RASH 1 0.0000
884 EMOTIONAL DISORDER 1 0.0000
885 GYNAECOMASTIA 1 0.0000
886 SWELLING 3 0.0000
887 BONE DENSITY DECREASED 1 0.0000
888 PARAESTHESIA 5 0.0000
889 MOOD SWINGS 1 0.0000
890 METABOLIC ACIDOSIS 1 0.0000
891 ATRIAL FIBRILLATION 3 0.0000
892 AMNESIA 2 0.0000
893 PRODUCT DOSE OMISSION 2 0.0000
894 STAPHYLOCOCCAL INFECTION 1 0.0000
895 BLOOD PRESSURE DECREASED 2 0.0000
896 LIP SWELLING 1 0.0000
897 SYNCOPE 3 0.0000
898 GAIT INABILITY 1 0.0000
899 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
900 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
901 HAEMATURIA 1 0.0000
902 GASTRIC DISORDER 1 0.0000
903 INJECTION SITE REACTION 2 0.0000
904 OFF LABEL USE 25 0.0000
905 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
906 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
907 MYELOSUPPRESSION 1 0.0000
908 VOMITING 13 0.0000
909 PANIC ATTACK 1 0.0000
910 UNDERDOSE 2 0.0000
911 RESTLESSNESS 1 0.0000
912 PRODUCT DOSE OMISSION ISSUE 8 0.0000
913 CHEST PAIN 5 0.0000
914 SEPSIS 3 0.0000
915 PRODUCT USE ISSUE 5 0.0000
916 GAIT DISTURBANCE 5 0.0000
917 HOSPITALISATION 4 0.0000
918 PLASMA CELL MYELOMA 1 0.0000
919 DISEASE PROGRESSION 3 0.0000
920 DRUG INTERACTION 4 0.0000
921 ABORTION SPONTANEOUS 1 0.0000
922 EXTRA DOSE ADMINISTERED 1 0.0000
923 DYSKINESIA 1 0.0000
924 INJECTION SITE ERYTHEMA 3 0.0000
925 SKIN EXFOLIATION 2 0.0000
926 RECTAL HAEMORRHAGE 1 0.0000
927 DEVICE DISLOCATION 1 0.0000
928 PSORIASIS 3 0.0000
929 DRY SKIN 3 0.0000
930 PULMONARY OEDEMA 1 0.0000
931 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
932 DEVICE ISSUE 2 0.0000
933 NEUTROPENIA 3 0.0000
934 SUICIDAL IDEATION 2 0.0000
935 DISEASE RECURRENCE 1 0.0000
936 PRODUCTIVE COUGH 1 0.0000
937 HYPOAESTHESIA 3 0.0000
938 LEUKOPENIA 1 0.0000
939 SOMNOLENCE 4 0.0000
940 FLUSHING 2 0.0000
941 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
942 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
943 INFLAMMATION 1 0.0000
944 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
945 PANCREATITIS 1 0.0000
946 DEPRESSED MOOD 1 0.0000
947 BRADYCARDIA 1 0.0000
948 HAEMATOCHEZIA 1 0.0000
949 THROMBOCYTOPENIA 2 0.0000
950 MUSCULAR WEAKNESS 2 0.0000
951 INCORRECT DOSE ADMINISTERED 4 0.0000
952 SEIZURE 2 0.0000
953 COVID-19 3 0.0000
954 BLADDER CANCER 1 0.0000
955 IRRITABILITY 1 0.0000
956 DEEP VEIN THROMBOSIS 1 0.0000
957 BLOOD CREATININE INCREASED 1 0.0000
958 NEOPLASM MALIGNANT 1 0.0000
959 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
960 BURNING SENSATION 1 0.0000
961 MOBILITY DECREASED 1 0.0000
962 INFECTION 2 0.0000
963 ACNE 1 0.0000
964 INJECTION SITE SWELLING 1 0.0000
965 INJECTION SITE PAIN 4 0.0000
966 INJECTION SITE HAEMORRHAGE 1 0.0000
967 CARDIAC FAILURE 1 0.0000
968 THROMBOSIS 1 0.0000
969 CONFUSIONAL STATE 2 0.0000
970 DRY MOUTH 1 0.0000
971 INFLUENZA LIKE ILLNESS 1 0.0000
972 DRUG DOSE OMISSION 2 0.0000
973 TREMOR 2 0.0000
974 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
975 DEATH 10 0.0000
976 PRODUCT STORAGE ERROR 1 0.0000
977 TACHYCARDIA 1 0.0000
978 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
979 ADVERSE DRUG REACTION 1 0.0000
980 ADVERSE EVENT 1 0.0000
981 CARDIAC DISORDER 1 0.0000
982 PULMONARY EMBOLISM 1 0.0000
983 DRUG INTOLERANCE 1 0.0000
984 ILLNESS 1 0.0000
985 HAEMORRHAGE 1 0.0000
986 OVERDOSE 2 0.0000
987 DRUG DEPENDENCE 1 0.0000
988 TOXICITY TO VARIOUS AGENTS 1 0.0000
989 NO ADVERSE EVENT 1 0.0000